Cargando…

Delay in the Detrended Fluctuation Analysis Crossover Point as a Risk Factor for Type 2 Diabetes Mellitus

Detrended Fluctuation Analysis (DFA) measures the complexity of a glucose time series obtained by means of a Continuous Glucose Monitoring System (CGMS) and has proven to be a sensitive marker of glucoregulatory dysfunction. Furthermore, some authors have observed a crossover point in the DFA, signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Varela, Manuel, Vigil, Luis, Rodriguez, Carmen, Vargas, Borja, García-Carretero, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884848/
https://www.ncbi.nlm.nih.gov/pubmed/27294154
http://dx.doi.org/10.1155/2016/9361958
_version_ 1782434424757944320
author Varela, Manuel
Vigil, Luis
Rodriguez, Carmen
Vargas, Borja
García-Carretero, Rafael
author_facet Varela, Manuel
Vigil, Luis
Rodriguez, Carmen
Vargas, Borja
García-Carretero, Rafael
author_sort Varela, Manuel
collection PubMed
description Detrended Fluctuation Analysis (DFA) measures the complexity of a glucose time series obtained by means of a Continuous Glucose Monitoring System (CGMS) and has proven to be a sensitive marker of glucoregulatory dysfunction. Furthermore, some authors have observed a crossover point in the DFA, signalling a change of dynamics, arguably dependent on the beta-insular function. We investigate whether the characteristics of this crossover point have any influence on the risk of developing type 2 diabetes mellitus (T2DM). To this end we recruited 206 patients at increased risk of T2DM (because of obesity, essential hypertension, or a first-degree relative with T2DM). A CGMS time series was obtained, from which the DFA and the crossover point were calculated. Patients were then followed up every 6 months for a mean of 17.5 months, controlling for the appearance of T2DM diagnostic criteria. The time to crossover point was a significant predictor risk of developing T2DM, even after adjusting for other variables. The angle of the crossover was not predictive by itself but became significantly protective when the model also considered the crossover point. In summary, both a delay and a blunting of the crossover point predict the development of T2DM.
format Online
Article
Text
id pubmed-4884848
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-48848482016-06-12 Delay in the Detrended Fluctuation Analysis Crossover Point as a Risk Factor for Type 2 Diabetes Mellitus Varela, Manuel Vigil, Luis Rodriguez, Carmen Vargas, Borja García-Carretero, Rafael J Diabetes Res Research Article Detrended Fluctuation Analysis (DFA) measures the complexity of a glucose time series obtained by means of a Continuous Glucose Monitoring System (CGMS) and has proven to be a sensitive marker of glucoregulatory dysfunction. Furthermore, some authors have observed a crossover point in the DFA, signalling a change of dynamics, arguably dependent on the beta-insular function. We investigate whether the characteristics of this crossover point have any influence on the risk of developing type 2 diabetes mellitus (T2DM). To this end we recruited 206 patients at increased risk of T2DM (because of obesity, essential hypertension, or a first-degree relative with T2DM). A CGMS time series was obtained, from which the DFA and the crossover point were calculated. Patients were then followed up every 6 months for a mean of 17.5 months, controlling for the appearance of T2DM diagnostic criteria. The time to crossover point was a significant predictor risk of developing T2DM, even after adjusting for other variables. The angle of the crossover was not predictive by itself but became significantly protective when the model also considered the crossover point. In summary, both a delay and a blunting of the crossover point predict the development of T2DM. Hindawi Publishing Corporation 2016 2016-05-16 /pmc/articles/PMC4884848/ /pubmed/27294154 http://dx.doi.org/10.1155/2016/9361958 Text en Copyright © 2016 Manuel Varela et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Varela, Manuel
Vigil, Luis
Rodriguez, Carmen
Vargas, Borja
García-Carretero, Rafael
Delay in the Detrended Fluctuation Analysis Crossover Point as a Risk Factor for Type 2 Diabetes Mellitus
title Delay in the Detrended Fluctuation Analysis Crossover Point as a Risk Factor for Type 2 Diabetes Mellitus
title_full Delay in the Detrended Fluctuation Analysis Crossover Point as a Risk Factor for Type 2 Diabetes Mellitus
title_fullStr Delay in the Detrended Fluctuation Analysis Crossover Point as a Risk Factor for Type 2 Diabetes Mellitus
title_full_unstemmed Delay in the Detrended Fluctuation Analysis Crossover Point as a Risk Factor for Type 2 Diabetes Mellitus
title_short Delay in the Detrended Fluctuation Analysis Crossover Point as a Risk Factor for Type 2 Diabetes Mellitus
title_sort delay in the detrended fluctuation analysis crossover point as a risk factor for type 2 diabetes mellitus
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884848/
https://www.ncbi.nlm.nih.gov/pubmed/27294154
http://dx.doi.org/10.1155/2016/9361958
work_keys_str_mv AT varelamanuel delayinthedetrendedfluctuationanalysiscrossoverpointasariskfactorfortype2diabetesmellitus
AT vigilluis delayinthedetrendedfluctuationanalysiscrossoverpointasariskfactorfortype2diabetesmellitus
AT rodriguezcarmen delayinthedetrendedfluctuationanalysiscrossoverpointasariskfactorfortype2diabetesmellitus
AT vargasborja delayinthedetrendedfluctuationanalysiscrossoverpointasariskfactorfortype2diabetesmellitus
AT garciacarreterorafael delayinthedetrendedfluctuationanalysiscrossoverpointasariskfactorfortype2diabetesmellitus